The ever increasing public outcry over the high price of medicines did little to stop drugmakers from raising prices again for 2020.

Prices have increased an average of 5.3 percent so far this year, according to consultant firm 3 Axis Advisors. Some of the biggest increases from large drugmakers so far come from Pfizer Inc.’s blockbuster vaccine Prevnar, and AbbVie Inc.’s best-seller arthritis medicine, Humira. The price of each was raised by just over 7 percent.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.